Keywords: positive, ph, iii, data, gsk, itp, drug

Positive Ph III data for GSK ITP drug

Article | 15 December 2008

Print This

UK drug major GlaxoSmithKline reported positive safety and efficacy results from the RAISE trial, a Phase III study of Promacta ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in